Work With Us
We are building a world-class team of professionals who are motivated by the opportunity to make a significant contribution to the health and well-being of others.
PIONEERING NEW TECHNOLOGIES
NeuroVista Corporation is an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
COMPANY NEWS
NeuroVista Raises $33.8 Million in Series B Financing, Company Changes Name from BioNeuronics
NeuroVista Named One of Washington's 100 Best Companies to Work For by Washington CEO Magazine
NeuroVista Hires Hugh H. Matsubayashi as Vice President of Intellectual Property
NeuroVista Hires Mary K. Moore as Vice President of Regulatory Affairs
NeuroVista Corporation Receives Gold Electrode Award for “Most Promising Start-up Company”